¼¼°èÀÇ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå(2024-2028³â)
Global Pharmacovigilance and Drug Safety Software Market 2024-2028
»óǰÄÚµå : 1581079
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,547,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,676,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾à¹°°¨½Ã¡¤ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023-2028³â¿¡ 6,910¸¸ ´Þ·¯·Î È®´ëÇϸç, ¿¹Ãø ±â°£ Áß 6.81%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾à¹°°¨½Ã¡¤ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25»çÀÇ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. À¯ÇØ»ç·ÊÀÇ ¹ß»ý·ü »ó½Â, Á¤ºÎÀÇ À¯¸®ÇÑ ±ÔÁ¦¿Í Á¤Ã¥, ½Å±Ô ºÐÀÚ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ½ÂÀÎ Áõ°¡ µîÀÌ ÀÌ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024³â
Á¾·á³â 2028³â
¿¹Ãø ±â°£ 2024-2028³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ(2024³â) 6.38%
CAGR 6.81%
ÁõºÐ¾× 6,910¸¸ ´Þ·¯

¾à¹°°¨½Ã¿¡¼­ AIÀÇ ÅëÇÕÀ» ÇâÈÄ ¼ö³â°£ ¾à¹°°¨½Ã¡¤ÀǾàǰ ¾ÈÀü¼º ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ÀÇ Çϳª·Î ½Äº°Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾à¹°°¨½Ã ¹× ÀǾàǰ ¾ÈÀü¼º Á¶»çÀÇ CRO¿¡ ´ëÇÑ ¿ÜÁÖÈ­ ¹× ÀǾàǰ Á¦Á¶¡¤°Ë»ç¿¡¼­ Ŭ¶ó¿ìµå ±â¼úÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀÌ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ±¸µµ

Á¦3Àå ½ÃÀå ±Ô¸ð Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five Forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦7Àå °í°´ »óȲ

Á¦8Àå Áö¿ªº° »óȲ

Á¦9Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå °æÀï ºÐ¼®

Á¦12Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The pharmacovigilance and drug safety software market is forecasted to grow by USD 69.1 million during 2023-2028, accelerating at a CAGR of 6.81% during the forecast period. The report on the pharmacovigilance and drug safety software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars.

Technavio's pharmacovigilance and drug safety software market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.38%
CAGR6.81%
Incremental Value$69.1 mn

By End-user

By Geographical Landscape

This study identifies the integration of ai in pharmacovigilance as one of the prime reasons driving the pharmacovigilance and drug safety software market growth during the next few years. Also, outsourcing pharmacovigilance and drug safety research to contract research organization (cros) and extensive adoption of cloud technologies in pharmaceutical manufacturing and testing will lead to sizable demand in the market.

The report on the pharmacovigilance and drug safety software market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software market vendors that include AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov SAS, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd.. Also, the pharmacovigilance and drug safety software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â